Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-09-22, Stock:JNJ, The news for the past five days is as follows:
2021-09-15: NEWS1: Moderna President details new clinical data on COVID-19 vaccine.NEWS2: Biden meets with CEOs, business leaders on vaccine mandates.NEWS3: Doctor on Biden’s vaccine mandate: ’Extraordinary times call for extraordinary measures’.NEWS4: Why Moderna stock has been in rally mode this month.NEWS5: Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now.NEWS6: Emergent (EBS) Inks COVID-19 Manufacturing Deal With Providence.NEWS7: Is JNJ Stock A Sell After It's Left Out Of The Covid Booster Shot Conversation?.NEWS8: 15 Dividend Stocks People Buy for Early Retirement.
2021-09-16: NEWS1: Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results.NEWS2: Johnson & Johnson (JNJ) Stock Moves -0.12%: What You Should Know.NEWS3: COVID-19 infections 'rivaling' what happened in winter 2020: Doctor.NEWS4: Top Research Reports for NVIDIA, Johnson & Johnson & Toyota.NEWS5: Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet.NEWS6: UPDATE 1-Iran approves U.S. firm J&J's shot as it fights fifth COVID wave.NEWS7: Booster shot debate heats up, LA County mandates vaccines for bar.NEWS8: Moderna president: ‘We don't really know' if future COVID-19 shots will be necessary.NEWS9: Iran approves U.S. J&J COVID shot as fifth wave spreads.NEWS10: 3 Stocks You Can Keep Forever.
2021-09-17: NEWS1: FDA advisory panel authorizes booster dose for those 65 & older.NEWS2: FDA advisory panel votes against approving COVID-19 booster.NEWS3: Wearing masks is something we should consider possibly in every flu, winter season: Doctor.NEWS4: 3 Value Dividend Stocks for High Total Returns.NEWS5: FDA panel votes for Pfizer's booster shot for high risk, ages 65+.NEWS6: Impact of NYC’s Covid-19 vaccination proof mandate for restaurants.NEWS7: Doctor: This conversation about boosters doesn’t take place just in the U.S..NEWS8: Janssen Shares Erdafitinib Combo Therapy Data In Bladder Cancer.NEWS9: FDA vaccine advisors weigh need for booster shots.NEWS10: Powell orders ethics review amid trading scandal.NEWS11: Is Moderna Winning on Vaccine Efficacy?.NEWS12: 3 Top Warren Buffett Stocks to Buy and Hold.
2021-09-20: NEWS1: Doctor reacts to U.S. travel ban changes.NEWS2: Why Protagonist Therapeutics Stock Plunged Today.NEWS3: Rockefeller Foundation President on the call for a ’COVID charter’ & ending ‘energy poverty’.NEWS4: LAPD, LAFD members sue over Los Angeles’ vaccine mandate.NEWS5: Early tests show Pfizer’s Covid-19 vaccine for kids ages 5 to 11 is ‘very safe’: Epidemiologist.NEWS6: India set to get first J&J COVID vaccine doses in October, says source.NEWS7: 15 Best Blue-Chip Stocks to Invest In.NEWS8: 10 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie.NEWS9: 3 reasons why FDA advisors rejected Pfizer’s booster for the general public.NEWS10: FDA Panel Vetoes PFE/BNTX Third Jab for All, Vaccine Stocks Down.
2021-09-21: NEWS1: J&J says booster shot greatly improves its COVID-19 vaccine’s efficacy as experts await FDA decision.NEWS2: Could natural COVID-19 immunity trump vaccine mandates?.NEWS3: Johnson & Johnson Shows Off Covid Boosters, But Can It Catch Moderna, Pfizer?.NEWS4: Dow Jones Rises As Fed Meeting Kicks Off; Growth Stocks To Watch Today.NEWS5: Booster shots for those 75+ is a 'no-brainer': Doctor.NEWS6: J&J announces promising Covid-19 booster data, delays on kids vaccine trial.NEWS7: Why These 10 Stocks Are on the Move on Tuesday.NEWS8: Dow Jones Trims Big Early Gains, Nasdaq Leads As Fed Meeting Starts.NEWS9: Johnson & Johnson Shows Off Covid Boosters, But Can It Catch Moderna, Pfizer?.NEWS10: Fed's FOMC Meeting in Focus.NEWS11: J&J says booster greatly improves COVID-19 vaccine efficacy as experts await FDA decision.NEWS12: Housing Data Better than Expected on Growth in Northeast.NEWS13: J&J announces promising COVID-19 booster data, delays on kids' vaccine trial.NEWS14: J&J Says Its Booster Shot Works, but Its Vaccine Remains Effective Without a Second Dose.NEWS15: 3 Underrated Warren Buffett Stocks That Are Smart Buys Right Now.NEWS16: Coronavirus tally: Global cases of COVID-19 top 229 million and J&J says booster vaccine shot increases antibodies.NEWS17: Johnson & Johnson says Phase 3 trial data confirms 'strong and long-lasting' protection from COVID-19 vaccine.NEWS18: J&J says second shot boosts protection for moderate-severe COVID-19 to 94%.NEWS19: J&J Says Covid-19 Vaccine Booster Two Months After First Shot Increases Protection.NEWS20: Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S..NEWS21: Jim Cramer on the Markets, Evergrande, J&J, Uber, Universal Music: Video.NEWS22: Premarket Movers Tuesday: Uber, Johnson & Johnson, Apple.NEWS23: Uber, Apple, ConocoPhillips Rise Premarket; Lennar Falls.NEWS24: J&J Gains on Claims Its Booster Shot Raises Immunity Against Covid.NEWS25: Johnson & Johnson Says Second COVID Vaccine Dose Boosts Overall Efficacy To 94%.

Answer: Decrease